Raised $2.5M in Series A funding, with an option for an additional $2.5M, necessitating a move of intellectual property (IP) and headquarters to the U.S..

is a South African-founded biotechnology startup that relocated its headquarters to Seattle, Washington , after securing $2.5 million in venture capital funding from Alethea Capital Management in late 2019.

The company specializes in , using genetic testing to provide patients and healthcare practitioners with actionable insights into health, nutrition, and fitness. Core Product: The 3X4 Genetics Report